The King of Ozempic Is Scared as Hell

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Related Content

Researchers Make Computer Models To Tackle Antibiotic Resistance

Was the infamous Stanford Prison Experiment a big fat lie?

Major Study Links 15 Factors to Early Dementia Risk : ScienceAlert

Leave a Comment